We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MGM:NYSEMGM Resorts International Analysis

Data as of 2026-06-18 - not real-time

$46.84

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

MGM’s stock is trading at $46.84, just above its 20‑day SMA of $45.69 and comfortably above the 50‑day and 200‑day averages, confirming a bullish trend despite a bearish MACD histogram and a decreasing volume flow. The RSI sits at 60, indicating continued buying pressure while the market sentiment index shows “Extreme Greed,” and the 30‑day volatility is elevated at nearly 58%, underscoring heightened short‑term risk. Fundamentally, revenue is growing modestly at 4.2% YoY, but profit margins remain thin at about 1% and the company carries a staggering debt load of $31.7 B versus $2.5 B of cash, resulting in a debt‑to‑equity ratio above 950%. Valuation metrics are mixed: the trailing P/E of 64 is markedly high, yet the forward P/E of 20 suggests the market may be pricing in future earnings acceleration.
The catalyst driving recent price action is the non‑binding all‑cash takeover proposal from People Inc. at roughly $48.30 per share, which sits just above the current price and offers limited upside while introducing integration and financing uncertainties. In this context, the stock appears fairly valued with a blend of growth and value characteristics, no dividend, and a risk profile dominated by leverage and sector cyclicality.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Takeover proposal providing near‑term price catalyst
  • Bullish SMA alignment and RSI above 50
  • High short‑term volatility and decreasing volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential acquisition premium limited to ~$48.30
  • Heavy debt burden constraining cash flow
  • Forward earnings growth expected but not yet realized

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic digital and luxury expansion under new ownership
  • Improving EPS guidance and forward P/E around 20
  • Opportunity to deleverage and enhance profitability over time

Key Metrics & Analysis

Financial Health

Revenue Growth4.20%
Profit Margin1.03%
P/E Ratio64.2
ROE13.49%
ROA1.84%
Debt/Equity951.19
P/B Ratio4.9
Op. Cash Flow$2.6B
Free Cash Flow$528.4M

Technical Analysis

TrendBullish
RSI60.4
Support$35.38
Resistance$51.59
MA 20$45.69
MA 50$41.13
MA 200$36.50
MACDBearish
VolumeDecreasing
Fear & Greed Index92.14

Valuation

Target Price$46.61
Upside/Downside-0.49%
GradeFair
TypeBlend

Risk Assessment

Beta1.00
Volatility57.90%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.